FDA Grand Rounds to Focus on Blood Safety, HIV

An upcoming Food and Drug Administration grand rounds will focus on advancing blood safety and patient health in HIV/AIDS through research on viral genome surveillance, diagnostic technologies, and biomarker discovery.

In this program, Indira K. Hewlett, PhD, senior biomedical research and product assessment service expert, and chief of the laboratory of molecular virology in the Division of Emerging and Transfusion Transmitted Diseases at the Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), will highlight FDA’s regulatory research efforts to enhance the effectiveness of testing. These efforts include the development of standards, evaluation of novel detection methodologies to improve virus detection and identification of biomarkers for latency in the context of pre-exposure prophylaxis (PrEP) and anti-retroviral therapy (ART), which have been widely implemented.

The program will take place 12-1 p.m. ET on Thursday, Sept. 12. Registration information is available online.